ConforMIS Inc (NASDAQ: CFMS) Settles Wright Medical Patent Litigation With Stryker Corp: BioSig Technologies Inc Sets IPO Price Per Share At $4.00: Finds Place In Russell Microcap

ConforMIS Inc (NASDAQ: CFMS) settled Tornier, Inc and Wright Medical Technology, Inc with Stryker Corporation.

Stryker Corporation took over Wright Medical Technology, Inc in November 2020. ConforMIS’s CEO, Mark Augusti is thrilled to resolve the patent litigation issues with Wright Medical on July 7, 2021. This settlement highlights the value and strength of its IP and its commitment to enforcing and protecting it. As per the terms of the deal, Stryker will make a one-time settlement fee to ConforMIS. 

BioSig Technologies Inc (NASDAQ: BSGM) set its IPO pricing at $4 for each share

BioSig Technologies Inc (NASDAQ: BSGM) has set $4/ share on July 2, 2021, for its previously announced IPO of 2.5 million shares. The company raises $10 million from this IPO. 

BioSig will close the Initial Public Offering (IPO) on July 7, 2021. The company appointed Laidlaw & Company (UK) Ltd as the book-running manager for this IPO. It will use the proceeds for the commercialization of the PURE EP System.

Installs PURE EP System at Weill Cornell Medical Center

BioSig installed the PURE EP System at Weill Cornell Medical Center in June 2021 in New York. A non-invasive class II device improves procedural efficiency and efficacy in electrophysiology. Over fifty doctors across 12 clinical sites have used this device to perform 1,000 cases. 

Kenneth L. Londoner, BioSig’s CEO, is excited to begin patient cases at one of the prominent cardiology centers in the nation. The company focuses on using its device at one of the best medical centers of excellence and offering the best patient care. 

BioSig so far sold its PURE EP to Mayo Foundation for Medical Education and Research and St. David’s HealthCare of Austin, Texas., Inc (NASDAQ: SPRT) gets a place in Russell Microcap Index, Inc. (NASDAQ: SPRT) will be included in the Russell Microcap Index with effect from June 28, 2021. Its membership will be valid for one year. CEO, Lance Rosenzweig, is pleased to get a place in the Russell Microcap Index. It increases recognition of to the broader investment community. 

Institutional investors and investment managers consider inclusion in the Russell Index as a benchmark for their investment strategies. 

Leave a Comment

Your email address will not be published.